Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Submitted by
admin
on October 22, 2010 - 7:26am
Source:
Bloomberg
News Tags:
diabetes
Amylin
Eli Lilly
Cephalon
M&A
Endo
Bydureon
Byetta
Headline:
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Do Not Allow Advertisers to Use My Personal information
